💥Stocks To Watch: SJVN, Angel One, Anand Rathi
Wealth, BGR Energy Systems, Sun Pharma, Banco
Products (India), Integra Engineering, 360 Wam
One, Lupin, Mahindra Lifespace Developers, GMR
Airports Infrastructure, Tata Motors, HCL Tech,
Infosys, Panacea Biotec, Dr. Reddy's
💥SJVN: Co. Secures LOA for 100 MW Solar Power
Project Development from RUVNL at a Projected
Cost of 6 Billion Rupees
💥Angel One: Q2 Cons Net Profit 3.04b Rupees Vs
2.14b (YoY) Q2 Revenue 10.48b Rupees Vs 7.45b
(YoY) Co Declared An Interim Dividend Of 12.70
Rupees Per Share
💥Anand Rathi Wealth: Q2 Cons Net Profit 575m
Rupees Vs 429m (YoY) Q2 Revenue 1.83b Rupees
Vs 1.36b (YoY) Q2 Ebitda 775m Rupees Vs 458m
(YoY) Q2 Ebitda Margin 42.43% Vs 33.68% (YoY)
Co. Declared An Interim Dividend Of 5 Rupees Per
Share
💥BGR Energy Systems: Co. Secures 1.13 Billion Rupee Order from Mangalore Refinery and Petrochemicals
💥Sun Pharma: Phase 4 Data Indicates Sustained Improvement in Dry Eye Disease with Cequa in
Patients Transitioning from Restasis
💥Banco Products (India): Co Unit Banco New Energy
Cooling Systems Ltd Has Started Commercial Production Of Heat Exchangers For Locomotives At Its Plant In Bharuch, Gujarat
💥Integra Engineering: Co. to Expand with 75,180
Square Feet Addition, Invests 218.3 Million Rupees
for Completion by Q2 2024
💥360 Wam One: Norges Bank Bought 32.76 Lakh Shares of Co For Rs 511.2 A Piece Morgan Stanley Sold 24.42 Lakh Shares Of Co At Rs 511.2
A Piece
💥Lupin: Co. Receives Tentative FDA Approval for
Calcium, Magnesium, Potassium, and Sodium
Oxybates Oral Solution
💥Lupin: Co. Receives Tentative FDA Approval for
Calcium, Magnesium, Potassium, and Sodium
Oxybates Oral Solution
💥Mahindra Lifespace Developers: Co Acquires Land
Parcel In Wagholi, Pune Land Has Saleable Area Potential of Approximately 1.5 Min Square Feet For Residential Development
💥GMR Airports Infrastructure: Sept Total Aircraft Movements Up 14% (YoY) Total Passenger Traffic
In Sept Up 23% (YoY)
💥Tata Motors: CJ Darcl Logistics MOUWith Tata Motors To Explore Indian Market - ET
💥HCL Tech: Q2 Cons Net Profit 38.32b Rupees
Vs 35.34b (QoQ); Est 37.6b Q2 Revenue 267b Rupees Vs 263b (QoQ) Q2 Ebit 49.19b Rupees Vs 44.38b (QoQ); Est 47.07b Q2 Ebit Margin 18.44% Vs 16.88% (QoQ); Est 17.5% Co Declared Ant Interim Dividend Of 12 Rupees Per Share
💥Infosys: Q2 Cons Net Profit 62.12b Rupees Vs 59.45b (QoQ); Est 62.25b Q2 Revenue 389.9b Rupees Vs 379b (QoQ); Est 384b Q2 Ebit 82.74b Rupees Vs 78.91b (QoQ); Est 80.70b Q2 Ebit
Margin 21.22% Vs 20.80% (QoQ); Est 21% || Co Declared An Interim Dividend Of 18 Rupees Per Share
💥Panacea Biotec: USFDA Inspects Co's PBPL Unit
in Himachal Pradesh; Issues FDA Form 483 with Nine Observations, Company to Address and Collaborate with FDA for Resolution
💥Dr. Reddy's: Co. Receives Form 483 with Nine Observations; US FDA Completes Product-Specific
Inspection at Bachupally Facility